Case Report

Severe Hyperuricemia as a Presenting Feature of Megaloblastic Anemia

Abstract

Hyperuricemia is commonly associated with hematological malignancies and high cell-turnover states. In megaloblastic anemia, ineffective erythropoiesis can increase purine breakdown, but severe hyperuricemia as an initial presentation—especially in children—is rare and may mimic malignancy. A 10-year-old girl with Down syndrome presented with failure to thrive, severe pancytopenia, hepatosplenomegaly, and marked hyperuricemia, raising strong suspicion of acute leukemia. Bone marrow examination revealed megaloblastic hematopoiesis without excess blasts. Treatment with vitamin B12 and folate led to rapid hematological recovery and normalization of uric acid levels. Megaloblastic anemia should be considered in children presenting with severe hyperuricemia and cytopenias, even when malignancy is suspected. Early diagnosis allows prompt, curative therapy and avoids unnecessary aggressive interventions.

[1] Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3-11. https://doi.org/10.1111/j.1365-2141.2004.05094.x
[2] Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767-2778. https://doi.org/10.1200/JCO.2007.15.0177
[3] Fox IH, Dotten DA, Marchant PJ. Alterations of human purine metabolism in megaloblastic anemia. Adv Exp Med Biol. 1977;76B:249-255. https://doi.org/10.1007/978-1-4684-3285- 5_36
[4] Smyth CJ. Disorders associated with hyperuricemia. Arthritis Rheum. 1975;18(6 Suppl):713-719. https://doi.org/10.1002/art.1780180712
[5] Hasle H. Pattern of malignant disorders in individuals with Down’s syndrome. Lancet Oncol. 2001;2(7):429-436. https://doi.org/10.1016/S1470-2045(00)00435-6
[6] Chandra J, Dewan P, Kumar P, Mahajan A, Singh P, Dhingra B, et al. Diagnosis, treatment and prevention of nutritional anemia in children: recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. Indian Pediatr. 2022;59(10):782-801. https://doi.org/10.1007/s13312-022-2622-2
[7] Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ. Severe megaloblastic anemia: vitamin deficiency and other causes. Cleve Clin J Med. 2020;87(3):153-164. https://doi.org/10.3949/ccjm.87a.19072
[8] Hooey MA, Crookston JH, Squires AH. Myeloproliferative disease complicated by megaloblastic anemia and hyperuricemia. Can Med Assoc J. 1965;93(17):935-937.
[9] Kubota M. Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab.
2019;2019:3480718. https://doi.org/10.1155/2019/3480718
[10] Gholipur-Shahraki T, Sadeghi A, Oghab P, Farrokhi P, Moghaddas A. Massive splenomegaly: a rare presentation of megaloblastic anemia. Int J Hematol Oncol Stem Cell Res. 2021;15(2):132-134. https://doi.org/10.18502/ijhoscr.v15i2.6044
Files
IssueVol 10 No 5 (2025): September - October QRcode
SectionCase Report(s)
Keywords
Hyperuricemia Megaloblastic anemia Malignancy
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Maji M, Radhakirshnan N, Singh S. Severe Hyperuricemia as a Presenting Feature of Megaloblastic Anemia. CRCP. 2026;10(5):236-240.